Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
RNA Analysis/ Transcriptomics Market Size Outlook: How Quickly Will Revenue Expand Through 2030?
The rna analysis/ transcriptomics market size has experienced rapid growth in recent years. Projections indicate it will expand from $8.74 billion in 2025 to $10.22 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.9%. Historically, this growth can be attributed to the proliferation of genomic research programs, the increasing adoption of rna sequencing technologies, a rise in funding for life sciences research, the availability of advanced laboratory instruments, and growing academic research activity.
The rna analysis/ transcriptomics market is projected to experience substantial expansion in the coming years. Its valuation is set to reach $19.04 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 16.8%. This anticipated growth during the forecast period is primarily driven by factors such as the increasing demand for precision medicine applications, the growing adoption of transcriptomics in drug discovery processes, the broadening scope of clinical diagnostics utilizing gene expression, increasing investments in bioinformatics infrastructure, and a heightened focus on personalized therapeutics. Key trends identified for the forecast period encompass the increasing integration of next-generation sequencing platforms, the rising prevalence of high-throughput transcriptomic profiling, the growing incorporation of advanced bioinformatics tools, the expansion of single-cell rna analysis techniques, and an enhanced emphasis on data reproducibility and accuracy.
Get A Free Sample Report With In-Depth Market Insights:
RNA Analysis/ Transcriptomics Market Demand Drivers: What’s Powering Industry Growth?
The increasing occurrence of chronic illnesses is anticipated to fuel the expansion of the RNA analysis/ transcriptomics market in the foreseeable future. Chronic diseases are defined as health conditions that persist for a minimum of one year, interfere with daily life, necessitate ongoing medical attention, or a combination thereof. This surge in chronic disease prevalence stems mainly from increasingly inactive lifestyles, where reduced daily physical movement compromises metabolic health and heightens the risk of developing long-term ailments. RNA analysis/transcriptomics plays a crucial role in managing chronic diseases by uncovering gene activity modifications that drive these conditions, thereby facilitating earlier identification, more precise diagnoses, and the creation of targeted, individualized therapies. An illustrative example from June 2024, provided by the National Health Service, a UK-based government department, showed that 3,615,330 individuals registered with a general practitioner (GP) received a diagnosis of non-diabetic hyperglycemia or pre-diabetes (a state characterized by elevated blood sugar levels, not yet reaching diabetic thresholds) in 2023. This represented an 18% increase from the 3,065,825 cases recorded in 2022. Consequently, the growing occurrence of chronic illnesses is propelling the expansion of the RNA analysis/ transcriptomics market.
RNA Analysis/ Transcriptomics Market Segmentation And Category Overview
The rna analysis/ transcriptomics market covered in this report is segmented –
1) By Product: Reagents/Consumables, Instruments, Software
2) By Technology, Microarrays, Sequencing, Polymerase Chain Reaction
3) By Application: Clinical Diagnostics, Drug Discovery, Toxicogenomics, Comparative Transcriptomics, RNA Interference
Subsegments:
1) By Reagents/Consumables: Nucleotides, Enzymes, Buffers and Solutions, Sample Preparation Kits, Sequencing Kits
2) By Instruments: Sequencers, Real-Time PCR Machines, Microarrays, Electrophoresis Systems, Robotic Liquid Handlers
3) By Software: Data Analysis Software, Bioinformatics Tools, Statistical Analysis Software, Visualization Software, Database Management Systems
RNA Analysis/ Transcriptomics Market Innovation Trends: What Developments Are Reshaping The Industry?
Leading companies within the RNA analysis/transcriptomics market are increasingly prioritizing the introduction of innovative product lines to secure a competitive advantage. The RNA Portfolio entails the development of novel technologies and solutions specifically designed to enhance the efficiency and effectiveness of RNA analysis. For instance, in May 2023, US-based biotechnology firm Twist Bioscience Corporation announced the launch of an RNA sequencing tools portfolio, which includes specific target enrichment capabilities for RNA and whole transcriptome sequencing. This also encompasses the Twist RNA Exome, the Twist RNA Library Prep Kit, and the Twist Ribosomal RNA (rRNA) and Hemoglobin (Globin) Depletion Kit. This portfolio delivers complete workflows for examining messenger RNA (mRNA) protein coding sequences, custom targets, and total RNA, enabling the measurement of the transcriptome. Additionally, these offerings are compatible for integration into clients’ existing workflows.
RNA Analysis/ Transcriptomics Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the rna analysis/ transcriptomics market are Affymetrix Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., GE Healthcare, Illumina Inc., QIAGEN N.V., F. Hoffmann-La Roche Ltd., Sigma-Aldrich Corporation, Thermo Fisher Scientific Inc., Fluidigm Corporation, Promega Corporation, bioMérieux S.A., CD Genomics Inc., Eurofins Scientific SE, Merck KGaA, Pacific Biosciences of California Inc., Danaher Corporation, Genewiz Inc., Oxford Nanopore Technologies Ltd., BGI Group, Genotypic Technology Pvt. Ltd., MedGenome Labs Pvt. Ltd., Xcelris Labs Ltd., Ocimum Biosolutions Ltd., Strand Life Sciences Pvt. Ltd., SciGenom Labs Pvt. Ltd., Oncocyte Corporation, Tempus Labs Inc., ArcherDX Inc., HTG Molecular Diagnostics Inc.
View The Full RNA Analysis/ Transcriptomics Market Report:
RNA Analysis/ Transcriptomics Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the RNA analysis/transcriptomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rna analysis/ transcriptomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
